Gait Speed and the Natural Course of Depressive Symptoms in Late Life; An Independent Association With Chronicity?

Journal of the American Medical Directors Association

Volumn 17, Issue 4, 2016, Pages 331-335

  Sanders, Joost B ^a,b   Bremmer, Marijke A ^b   Comijs, Hannie C ^b,c   Deeg, Dorly J H ^b   Beekman, Aartjan T F ^b,c  

^a Altrecht   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GGZ InGeest   (Netherlands)

Author keywords

Gait speed; Late life depression; Natural course; Prognosis

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; C REACTIVE PROTEIN;

ADULT; AGED; ARTHRITIS; ARTICLE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONICITY; COMORBIDITY; DISEASE COURSE; DISEASE MARKER; FEMALE; GAIT; HUMAN; LATE LIFE DEPRESSION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PSYCHOSOMATIC DISORDER; REMISSION; VASCULAR DISEASE; WALKING SPEED; AGING; DEPRESSION; LONGITUDINAL STUDY; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; CHRONIC DISEASE; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; RISK FACTORS; WALKING SPEED;

EID: 84953210507     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.11.016     Document Type: Article

References (39)

1. Parker G., Roy K., Hadzi-Pavlovic D., et al. Subtyping depression by clinical features: The Australasian database. Acta Psychiatr Scand 2000, 101:21-28.
2. Pier M.P., Hulstijn W., Sabbe B.G. No psychomotor slowing in fine motor tasks in dysthymia. J Affect Disord 2004, 83:109-120.
3. Hickie I., Mason C., Parker G., Brodaty H. Prediction of ECT response: Validation of a refined sign-based (CORE) system for defining melancholia. Br J Psychiatry 1996, 169:68-74.
4. Schrijvers D., Hulstijn W., Sabbe B.G. Psychomotor symptoms in depression: A diagnostic, pathophysiological and therapeutic tool. J Affect Disord 2008, 109:1-20.
5. Lockwood K.A., Alexopoulos G.S., van Gorp W.G. Executive dysfunction in geriatric depression. Am J Psychiatry 2002, 159:1119-1126.
6. Alexopoulos G.S., Kiosses D.N., Heo M., et al. Executive dysfunction and the course of geriatric depression. Biol Psychiatry 2005, 58:204-210.
7. Sheline Y.I., Pieper C.F., Barch D.M., et al. Support for the vascular depression hypothesis in late-life depression: Results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 2010, 67:277-285.
8. Sanders J.B., Bremmer M.A., Comijs H.C., et al. Cognitive functioning and the natural course of depressive symptoms in late life. Am J Geriatr Psychiatry 2011, 19:664-672.
9. Lemke M.R., Wendorff T., Mieth B., et al. Spatiotemporal gait patterns during over ground locomotion in major depression compared with healthy controls. J Psychiatr Res 2000, 34:277-283.
10. Guralnik J.M., Ferrucci L., Pieper C.F., et al. Lower extremity function and subsequent disability: Consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000, 55:M221-M231.
11. Abellan van Kan G., Rolland Y., Andrieu S., et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 2009, 13:881-889.
12. Alexopoulos G.S., Meyers B.S., Young R.C., et al. "Vascular depression" hypothesis. Arch Gen Psychiatry 1997, 54:915-922.
13. Almeida O.P. Vascular depression: Myth or reality?. Int Psychogeriatr 2008, 20:645-652.
14. Alexopoulos G.S., Morimoto S.S. The inflammation hypothesis in geriatric depression. Int J Geriatr Psychiatry 2011, 26:1109-1118.
15. Bremmer M.A., Beekman A.T., Deeg D.J., et al. Inflammatory markers in late-life depression: Results from a population-based study. J Affect Disord 2008, 106:249-255.
16. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
17. Schneider C., Jick S.S., Bothner U., Meier C.R. COPD and the risk of depression. Chest 2010, 137:341-347.
18. Dickens C., McGowan L., Clark-Carter D., Creed F. Depression in rheumatoid arthritis: A systematic review of the literature with meta-analysis. Psychosom Med 2002, 64:52-60.
19. Karpman C., DePew Z.S., LeBrasseur N.K., et al. Determinants of gait speed in COPD. Chest 2014, 146:104-110.
20. Dawson J., Linsell L., Zondervan K., et al. Epidemiology of hip and knee pain and its impact on overall health status in older adults. Rheumatology (Oxford) 2004, 43:497-504.
21. Dominick C.H., Blyth F.M., Nicholas M.K. Unpacking the burden: Understanding the relationships between chronic pain and comorbidity in the general population. Pain 2012, 153:293-304.
22. Huisman M., Poppelaars J., van der Horst M., et al. Cohort profile: The Longitudinal Aging Study Amsterdam. Int J Epidemiol 2011, 40:868-876.
23. Radloff L.S. The CES-D scale: A self report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
24. Robins L.N., Helzer J.E., Croughan J., Ratcliff K.S. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry 1981, 38:381-389.
25. Beekman A.T., Deeg D.J., Van L.J., et al. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): Results from a community-based sample of older subjects in The Netherlands. Psychol Med 1997, 27:231-235.
26. Beekman A.T., Geerlings S.W., Deeg D.J., et al. The natural history of late-life depression: A 6-year prospective study in the community. Arch Gen Psychiatry 2002, 59:605-611.
27. Jacobson N.S., Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991, 59:12-19.
28. Cooper R., Kuh D., Hardy R. Objectively measured physical capability levels and mortality: Systematic review and meta-analysis. BMJ 2010, 341:c4467.
29. Sanders J.B., Bremmer M.A., Deeg D.J., Beekman A.T. Do depressive symptoms and gait speed impairment predict each other's incidence? A 16-year prospective study in the community. J Am Geriatr Soc 2012, 60:1673-1680.
30. Sonnenberg C.M., Beekman A.T., Deeg D.J., Van Tilburg W. Drug treatment in depressed elderly in the Dutch community. Int J Geriatr Psychiatry 2003, 18:99-104.
31. Bremmer M.A., Hoogendijk W.J., Deeg D.J., et al. Depression in older age is a risk factor for first ischemic cardiac events. Am J Geriatr Psychiatry 2006, 14:523-530.
32. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Intern Med 1993, 153:154-183.
33. Savage R.D. Alphabet coding task 15 1984, Murdoch University, Western Australia.
34. Comijs H.C., van Tilburg T., Geerlings S.W., et al. Do severity and duration of depressive symptoms predict cognitive decline in older persons? Results of the Longitudinal Aging Study Amsterdam. Aging Clin Exp Res 2004, 16:226-232.
35. Brandler T.C., Wang C., Oh-Park M., et al. Depressive symptoms and gait dysfunction in the elderly. Am J Geriatr Psychiatry 2012, 20:425-432.
36. Withall A., Harris L.M., Cumming S.R. The relationship between cognitive function and clinical and functional outcomes in major depressive disorder. Psychol Med 2009, 39:393-402.
37. Chen H.M., Tsai C.M., Wu Y.C., et al. Randomised controlled trial on the effectiveness of home-based walking exercise on anxiety, depression and cancer-related symptoms in patients with lung cancer. Br J Cancer 2015, 112:438-445.
38. Cohen H. Statisical Power Analysis for the Behavioral Sciences 1985, Lawrence A. Erlbaum Associates, Hillsdale NJ.
39. Judd L.L., Akiskal H.S., Maser J.D., et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998, 55:694-700.